Completely agree I had mentioned 2-3 months ago that blended data is already too late and won’t make any significant difference in SP unless they clearly define the end game and how to reach there financially and logistically . Market doesn’t reward uncertainty . At ASCO all they did was create more uncertainty as to when unblinding will happen . They pretty much left it to any one imagination . I wish they had hired couple of years ago, a seasoned hedge fund manager and an exec from some BP who has taken trials to completion and approvals instead of hiring Black and a PR firms .
News 
Market Data 
Discover 
